Oncology & Cancer

Drug triggers immune cells to attack prostate cancer

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells. It triggers immune cells to attack, helps the immune cells penetrate the tumor, ...

Medical research

Decoy receptor protects against omicron infection

They say that the best defense is a good offense; and now, researchers from Japan have found that the best defense against coronavirus disease 2019 (COVID-19) infection could be a good decoy.

Oncology & Cancer

Armed CAR-T cells to better fight cancer

Immunotherapy is increasingly becoming a successful way to treat cancer. Researchers at Uppsala University have now developed armed CAR-T cells that reinforce the immune defense against cancer and that could increase the ...

Neuroscience

Researchers boost human mental function with brain stimulation

In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related to self-control and mental flexibility ...

Diseases, Conditions, Syndromes

High virus count in the lungs drives COVID-19 deaths

A buildup of coronavirus in the lungs is likely behind the steep mortality rates seen in the pandemic, a new study finds. The results contrast with previous suspicions that simultaneous infections, such as bacterial pneumonia ...

Diseases, Conditions, Syndromes

Common cold combats COVID-19

Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19, Yale researchers have found.

Diseases, Conditions, Syndromes

When COVID-19 meets flu season

As if the COVID-19 pandemic isn't scary enough, the flu season is not far away. How severe will the flu season be as it converges with the COVID-19 outbreak? What can we do to prepare?

page 2 from 26